Sleep in COPD: an understudied and clinically important issue
- 1Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
Abstract
This review provides an overview of objective and subjective sleep characteristics in the general chronic obstructive pulmonary disease (COPD) population and discusses associations with airway symptoms, psychological factors, quality of life, and common sleep disorders. Available studies indicate that patients with COPD often exhibit altered sleep architecture, including increased light sleep, reduced slow-wave and rapid eye movement (REM) sleep, frequent arousals, reduced sleep efficiency, and shorter total sleep duration. Subjectively, 40–70% of patients report poor sleep quality, characterized by difficulty initiating or maintaining sleep and increased daytime sleepiness. Nocturnal respiratory symptoms such as dyspnea, cough, wheeze, sputum production, and hypoxemia may contribute to sleep disruption. Common sleep disorders such as insomnia, obstructive sleep apnea (OSA), and restless legs syndrome (RLS) are seen more frequently in COPD, and poor sleep may also negatively affect COPD outcomes through mechanisms such as systemic inflammation, reduced physical activity, and impaired treatment adherence. Sleep disturbances are further associated with anxiety, depression, fatigue, and reduced quality of life. Assessing sleep and sleep quality and treating both COPD and sleep disorders effectively in this patient population are of importance and would likely improve not only sleep and airway symptoms but also quality of life and overall clinical outcomes.
Related
- Tiotropium and clinically important deterioration in mild-to-moderate chronic obstructive pulmonary disease: a post hoc win ratio analysis of the Tie-COPD study.
- Tranexamic acid use and progression to clinically important bleeding in critically ill patients with non-clinically important non-variceal upper gastrointestinal bleeding: a retrospective cohort study
- Double‐Bundle Anterior Cruciate Ligament Reconstruction Provides Superior Short‐to‐Midterm Rotational Stability But Not Clinically Important Functional Gains Over Single‐Bundle: A Systematic Review and Meta‐analysis
- Identification of the Minimal Clinically Important Difference (MCID) for Childhood Autism Rating Scale Second Edition (CARS2) in children with ASD
- Temporal Trends in Antimicrobial Resistance Among Clinically Important Pathogens in Iraq, 2021-2024: Implications for Empirical Antimicrobial Therapy
BibTeX
@article{theorellhaglow2026sleep,
title = {{Sleep in COPD: an understudied and clinically important issue}},
author = {Jenny Theorell-Haglöw},
journal = {Upsala Journal of Medical Sciences},
year = {2026},
month = nov,
doi = {10.48101/ujms.v131.14699},
url = {https://doi.org/10.48101/ujms.v131.14699},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Sleep in COPD: an understudied and clinically important issue
AU - Jenny Theorell-Haglöw
PY - 2026
DA - 2026/11/03
JO - Upsala Journal of Medical Sciences
DO - 10.48101/ujms.v131.14699
UR - https://doi.org/10.48101/ujms.v131.14699
AB - This review provides an overview of objective and subjective sleep characteristics in the general chronic obstructive pulmonary disease (COPD) population and discusses associations with airway symptoms, psychological factors, quality of life, and common sleep disorders. Available studies indicate that patients with COPD often exhibit altered sleep architecture, including increased light sleep, reduced slow-wave and rapid eye movement (REM) sleep, frequent arousals, reduced sleep efficiency, and shorter total sleep duration. Subjectively, 40–70% of patients report poor sleep quality, characterized by difficulty initiating or maintaining sleep and increased daytime sleepiness. Nocturnal respiratory symptoms such as dyspnea, cough, wheeze, sputum production, and hypoxemia may contribute to sleep disruption. Common sleep disorders such as insomnia, obstructive sleep apnea (OSA), and restless legs syndrome (RLS) are seen more frequently in COPD, and poor sleep may also negatively affect COPD outcomes through mechanisms such as systemic inflammation, reduced physical activity, and impaired treatment adherence. Sleep disturbances are further associated with anxiety, depression, fatigue, and reduced quality of life. Assessing sleep and sleep quality and treating both COPD and sleep disorders effectively in this patient population are of importance and would likely improve not only sleep and airway symptoms but also quality of life and overall clinical outcomes.
SN - 0300-9734
SN - 2000-1967
ER -